Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
Katrine Holtz Thorhauge(University of Southern Denmark), Aleksander Krag(University of Southern Denmark), Bjørn Stæhr Madsen(Odense University Hospital), Stine Johansen(University of Southern Denmark), Ditlev Nytoft Rasmussen(Odense University Hospital), Maja Thiele(Odense University Hospital), Sönke Detlefsen(Odense University Hospital), Lars Melholt Rasmussen(University of Southern Denmark), Steen Antonsen(Odense University Hospital), Katrine Prier Lindvig(University of Southern Denmark)
Cited by 14
Related Papers
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
|Ultraschall in der Medizin - European Journal of Ultrasound|2017|998
Noninvasive proteomic biomarkers for alcohol-related liver disease
|Nature Medicine|2022|318
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
|Journal of Hepatology|2023|213
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study
|The Lancet. Gastroenterology & hepatology|2024|152
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
|Journal of Hepatology|2021|141